These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6428775)

  • 21. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoproteins B and A-I and coronary artery disease in humans.
    Brunzell JD; Sniderman AD; Albers JJ; Kwiterovich PO
    Arteriosclerosis; 1984; 4(2):79-83. PubMed ID: 6422918
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis.
    Uiterwaal CS; Witteman JC; van Stiphout WA; Krauss XH; de Bruijn AM; Hofman A; Grobbee DE
    Atherosclerosis; 1996 May; 122(2):235-44. PubMed ID: 8769686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M; Nowicka G
    Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154
    [No Abstract]   [Full Text] [Related]  

  • 25. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of HDL-apolipoprotein A-I and HDL-Cholesterol to risk factors of coronary heart disease: initial results of the prospective epidemiological study in company employees in Westfalia.
    Assmann G; Funke H; Schriewer H
    J Clin Chem Clin Biochem; 1982 May; 20(5):287-9. PubMed ID: 7108447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative value of lipids and apoproteins in coronary heart disease.
    De Backer G; Rosseneu M; Deslypere JP
    Atherosclerosis; 1982 Apr; 42(2-3):197-203. PubMed ID: 6803813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy.
    Grundy SM
    Circulation; 2002 Nov; 106(20):2526-9. PubMed ID: 12427645
    [No Abstract]   [Full Text] [Related]  

  • 33. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical chemical indexes and severity of coronary atherosclerosis.
    Lippi U; Cappelletti P; Signori D; Burelli C
    Clin Chim Acta; 1983 Jun; 130(3):283-9. PubMed ID: 6872262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption].
    Torkhovskaia TI; Khalilov EM; Oleĭnik IA; Kliuchnikova ZhI; Klimov AN
    Kardiologiia; 1989 Oct; 29(10):60-4. PubMed ID: 2615161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia.
    Goldberg AP; Lim A; Kolar JB; Grundhauser JJ; Steinke FH; Schonfeld G
    Atherosclerosis; 1982 Jun; 43(2-3):355-68. PubMed ID: 6889432
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative serum apolipoprotein studies in ischaemic heart disease and control subjects.
    Onitiri AC; Jover E
    Clin Chim Acta; 1980 Nov; 108(1):25-30. PubMed ID: 7470245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 39. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ingestion of egg raises plasma low density lipoproteins in free-living subjects.
    Sacks FM; Salazar J; Miller L; Foster JM; Sutherland M; Samonds KW; Albers JJ; Kass EH
    Lancet; 1984 Mar; 1(8378):647-9. PubMed ID: 6142348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.